Potential optimized route for mesenchymal stem cell transplantation in a rat model of cerebral palsy.

[1]  Gordana S. Velikic,et al.  Stem Cell Homing in Intrathecal Applications and Inspirations for Improvement Paths , 2022, International journal of molecular sciences.

[2]  A. Hoon,et al.  Cerebral palsy and the placenta: A review of the maternal-placental-fetal origins of cerebral palsy. , 2022, Experimental Neurology.

[3]  Y. Chang,et al.  BDNF-Overexpressing Engineered Mesenchymal Stem Cells Enhances Their Therapeutic Efficacy against Severe Neonatal Hypoxic Ischemic Brain Injury , 2021, International journal of molecular sciences.

[4]  S. Cavallaro,et al.  Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? , 2021, Cells.

[5]  Lu Wang,et al.  Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells , 2021, Frontiers in Immunology.

[6]  H. Forssberg,et al.  Early Intervention for Children Aged 0 to 2 Years With or at High Risk of Cerebral Palsy: International Clinical Practice Guideline Based on Systematic Reviews. , 2021, JAMA pediatrics.

[7]  D. Surbek,et al.  Human Wharton’s Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways , 2021, Frontiers in Cell and Developmental Biology.

[8]  V. Nurcombe,et al.  Age-Related Changes in the Inflammatory Status of Human Mesenchymal Stem Cells: Implications for Cell Therapy , 2021, Stem cell reports.

[9]  Yunxian Xu,et al.  Constraint-Induced Movement Therapy Promotes Neural Remodeling and Functional Reorganization by Overcoming Nogo-A/NgR/RhoA/ROCK Signals in Hemiplegic Cerebral Palsy Mice , 2021, Neurorehabilitation and neural repair.

[10]  Jessica M Sun,et al.  Stem cell therapies in cerebral palsy and autism spectrum disorder , 2021, Developmental medicine and child neurology.

[11]  Jing Liu,et al.  Progress in clinical trials of stem cell therapy for cerebral palsy , 2020, Neural regeneration research.

[12]  P. Gressens,et al.  Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species , 2020, Journal of neurochemistry.

[13]  U. Felderhoff-Müser,et al.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles Reduce Neuroinflammation, Promote Neural Cell Proliferation and Improve Oligodendrocyte Maturation in Neonatal Hypoxic-Ischemic Brain Injury , 2020 .

[14]  T. Vos,et al.  Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, The Lancet.

[15]  Reint K Jellema,et al.  Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key , 2020, Cells.

[16]  B. Xie,et al.  Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials , 2020, Stem cells international.

[17]  J. Gécz,et al.  Definition and diagnosis of cerebral palsy in genetic studies: a systematic review , 2020, Developmental medicine and child neurology.

[18]  J. Puyal,et al.  Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models , 2020, Frontiers in Cell and Developmental Biology.

[19]  K. Houkin,et al.  Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease , 2020, Stem cells international.

[20]  Zhousheng Xiao,et al.  Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial , 2020, Stem Cell Research & Therapy.

[21]  D. Na,et al.  Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain , 2020, International journal of molecular sciences.

[22]  A. te Velde,et al.  State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy , 2020, Current Neurology and Neuroscience Reports.

[23]  A. Teixeira,et al.  Inflammatory biomarkers in children with cerebral palsy: A systematic review. , 2019, Research in developmental disabilities.

[24]  D. Crooks,et al.  Oligodendrocytes in Development, Myelin Generation and Beyond , 2019, Cells.

[25]  F. Triolo,et al.  Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application , 2019, Front. Immunol..

[26]  H. Forssberg,et al.  Can Neonatal Systemic Inflammation and Hypoxia Yield a Cerebral Palsy-Like Phenotype in Periadolescent Mice? , 2019, Molecular Neurobiology.

[27]  Jee-Yin Ahn,et al.  Human UCB-MSCs treatment upon intraventricular hemorrhage contributes to attenuate hippocampal neuron loss and circuit damage through BDNF-CREB signaling , 2018, Stem Cell Research & Therapy.

[28]  M. Tsuji,et al.  Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat , 2018, Front. Neurol..

[29]  N. Paneth,et al.  The complex aetiology of cerebral palsy , 2018, Nature Reviews Neurology.

[30]  J. Galipeau,et al.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.

[31]  B. V. van Bon,et al.  Analysis of 182 cerebral palsy transcriptomes points to dysregulation of trophic signalling pathways and overlap with autism , 2018, Translational Psychiatry.

[32]  D. Roy,et al.  Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells , 2018, Stem cells.

[33]  Ang Li,et al.  Exosomes secreted by stem cells from human exfoliated deciduous teeth contribute to functional recovery after traumatic brain injury by shifting microglia M1/M2 polarization in rats , 2017, Stem Cell Research & Therapy.

[34]  Sarah McIntyre,et al.  Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment , 2017, JAMA pediatrics.

[35]  F. Emmrich,et al.  Mesenchymal Stem Cell‐Derived Microvesicles Modulate Lipopolysaccharides‐Induced Inflammatory Responses to Microglia Cells , 2016, Stem cells.

[36]  Meijuan Huang,et al.  Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response , 2015, Cellular and Molecular Immunology.

[37]  Roustem Khazipov,et al.  Atlas of the Postnatal Rat Brain in Stereotaxic Coordinates , 2015, Front. Neuroanat..

[38]  G. Camussi,et al.  The secretome of mesenchymal stromal cells: Role of extracellular vesicles in immunomodulation. , 2015, Immunology letters.

[39]  D. Ferriero,et al.  The role of inflammation in perinatal brain injury , 2015, Nature Reviews Neurology.

[40]  G. Clowry,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License What Are the Best Animal Models for Testing Early Intervention in Cerebral Palsy? , 2022 .

[41]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[42]  Changlian Zhu,et al.  The immune response after hypoxia-ischemia in a mouse model of preterm brain injury , 2014, Journal of Neuroinflammation.

[43]  Yaojiong Wu,et al.  The Size of Mesenchymal Stem Cells is a Significant Cause of Vascular Obstructions and Stroke , 2014, Stem Cell Reviews and Reports.

[44]  F. Locatelli,et al.  Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease , 2013, British journal of haematology.

[45]  W. Fibbe,et al.  Mesenchymal stromal cells: sensors and switchers of inflammation. , 2013, Cell stem cell.

[46]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[47]  D. Ferriero,et al.  Mesenchymal Stem Cell Transplantation Attenuates Brain Injury After Neonatal Stroke , 2013, Stroke.

[48]  G. Brewer,et al.  miR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2* , 2013, The Journal of Biological Chemistry.

[49]  G. Gurtner,et al.  Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. , 2012, Advances in wound care.

[50]  P. Gressens,et al.  Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? , 2012, The Lancet Neurology.

[51]  R. Thorne,et al.  Intranasal delivery of biologics to the central nervous system. , 2012, Advanced drug delivery reviews.

[52]  C. V. van Blitterswijk,et al.  Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. , 2012, Tissue engineering. Part B, Reviews.

[53]  A. Kavelaars,et al.  Mesenchymal stem cells as a treatment for neonatal ischemic brain damage , 2012, Pediatric Research.

[54]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[55]  A. Kavelaars,et al.  Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain , 2011, Brain, Behavior, and Immunity.

[56]  A. Kavelaars,et al.  Repeated Mesenchymal Stem Cell Treatment after Neonatal Hypoxia–Ischemia Has Distinct Effects on Formation and Maturation of New Neurons and Oligodendrocytes Leading to Restoration of Damage, Corticospinal Motor Tract Activity, and Sensorimotor Function , 2010, The Journal of Neuroscience.

[57]  M. Chopp,et al.  Effects of Administration Route on Migration and Distribution of Neural Progenitor Cells Transplanted into Rats with Focal Cerebral Ischemia, an MRI Study , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[59]  Guang-qian Zhou,et al.  SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model , 2008, Brain Research.

[60]  B. Dan,et al.  A report: the definition and classification of cerebral palsy April 2006 , 2007, Developmental medicine and child neurology. Supplement.

[61]  V. Eder,et al.  Influence of hypoxia on the domiciliation of Mesenchymal Stem Cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? , 2005, Respiratory research.

[62]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[63]  R. Vannucci,et al.  Influence of Mild Hypothermia on Hypoxic-Ischemic Brain Damage in the Immature Rat , 1993, Pediatric Research.

[64]  S. Graham,et al.  Advances in cerebral palsy biomarkers. , 2021, Advances in clinical chemistry.

[65]  H. Qian,et al.  Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair. , 2019, American journal of translational research.